UniProt ID | SERC3_HUMAN | |
---|---|---|
UniProt AC | Q13530 | |
Protein Name | Serine incorporator 3 | |
Gene Name | SERINC3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 473 | |
Subcellular Localization |
Cell membrane Multi-pass membrane protein . Golgi apparatus membrane Multi-pass membrane protein . Cytoplasm, perinuclear region . (Microbial infection) Upon HIV-1 infection, it is redirected to perinuclear region following interaction with HIV- |
|
Protein Description | Restriction factor required to restrict infectivity of lentiviruses, such as HIV-1: acts by inhibiting an early step of viral infection. Impairs the penetration of the viral particle into the cytoplasm. [PubMed: 26416733] | |
Protein Sequence | MGAVLGVFSLASWVPCLCSGASCLLCSCCPNSKNSTVTRLIYAFILLLSTVVSYIMQRKEMETYLKKIPGFCEGGFKIHEADINADKDCDVLVGYKAVYRISFAMAIFFFVFSLLMFKVKTSKDLRAAVHNGFWFFKIAALIGIMVGSFYIPGGYFSSVWFVVGMIGAALFILIQLVLLVDFAHSWNESWVNRMEEGNPRLWYAALLSFTSAFYILSIICVGLLYTYYTKPDGCTENKFFISINLILCVVASIISIHPKIQEHQPRSGLLQSSLITLYTMYLTWSAMSNEPDRSCNPNLMSFITRITAPTLAPGNSTAVVPTPTPPSKSGSLLDSDNFIGLFVFVLCLLYSSIRTSTNSQVDKLTLSGSDSVILGDTTTSGASDEEDGQPRRAVDNEKEGVQYSYSLFHLMLCLASLYIMMTLTSWYSPDAKFQSMTSKWPAVWVKISSSWVCLLLYVWTLVAPLVLTSRDFS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
11 | Ubiquitination | VLGVFSLASWVPCLC HHHHHHHHHHHHHHH | 10.51 | 27667366 | |
12 | Ubiquitination | LGVFSLASWVPCLCS HHHHHHHHHHHHHHC | 33.62 | - | |
34 | N-linked_Glycosylation | SCCPNSKNSTVTRLI HCCCCCCCHHHHHHH | 42.61 | UniProtKB CARBOHYD | |
42 | Phosphorylation | STVTRLIYAFILLLS HHHHHHHHHHHHHHH | 10.47 | 25404012 | |
49 | Phosphorylation | YAFILLLSTVVSYIM HHHHHHHHHHHHHHH | 21.08 | 25404012 | |
50 | Phosphorylation | AFILLLSTVVSYIMQ HHHHHHHHHHHHHHH | 25.54 | 25404012 | |
53 | Phosphorylation | LLLSTVVSYIMQRKE HHHHHHHHHHHHHHH | 12.47 | 25404012 | |
54 | Phosphorylation | LLSTVVSYIMQRKEM HHHHHHHHHHHHHHH | 6.71 | 25404012 | |
63 | Phosphorylation | MQRKEMETYLKKIPG HHHHHHHHHHHHCCC | 32.61 | 25404012 | |
64 | Phosphorylation | QRKEMETYLKKIPGF HHHHHHHHHHHCCCC | 11.83 | 25404012 | |
66 | Ubiquitination | KEMETYLKKIPGFCE HHHHHHHHHCCCCCC | 37.94 | 27667366 | |
67 | Ubiquitination | EMETYLKKIPGFCEG HHHHHHHHCCCCCCC | 52.09 | 29967540 | |
72 | S-palmitoylation | LKKIPGFCEGGFKIH HHHCCCCCCCCEEEE | 6.18 | 29575903 | |
77 | Ubiquitination | GFCEGGFKIHEADIN CCCCCCEEEECCCCC | 46.56 | 29967540 | |
87 | Ubiquitination | EADINADKDCDVLVG CCCCCCCCCCCEECC | 58.82 | 29967540 | |
294 | Phosphorylation | MSNEPDRSCNPNLMS HCCCCCCCCCCCHHH | 26.15 | - | |
295 | S-palmitoylation | SNEPDRSCNPNLMSF CCCCCCCCCCCHHHH | 11.62 | 29575903 | |
310 | Phosphorylation | ITRITAPTLAPGNST HHHHCCCCCCCCCCC | 32.84 | - | |
317 | O-linked_Glycosylation | TLAPGNSTAVVPTPT CCCCCCCCEEECCCC | 27.72 | OGP | |
322 | Phosphorylation | NSTAVVPTPTPPSKS CCCEEECCCCCCCCC | 28.34 | 25332170 | |
322 | O-linked_Glycosylation | NSTAVVPTPTPPSKS CCCEEECCCCCCCCC | 28.34 | OGP | |
327 | Phosphorylation | VPTPTPPSKSGSLLD ECCCCCCCCCCCCCC | 40.43 | 25332170 | |
355 | Phosphorylation | LLYSSIRTSTNSQVD HHHHHHHCCCCCCCC | 37.93 | - | |
356 | Phosphorylation | LYSSIRTSTNSQVDK HHHHHHCCCCCCCCE | 18.75 | - | |
357 | Phosphorylation | YSSIRTSTNSQVDKL HHHHHCCCCCCCCEE | 37.97 | 25954137 | |
363 | Ubiquitination | STNSQVDKLTLSGSD CCCCCCCEEEECCCC | 44.51 | 33845483 | |
365 | Phosphorylation | NSQVDKLTLSGSDSV CCCCCEEEECCCCEE | 25.31 | 25849741 | |
367 | Phosphorylation | QVDKLTLSGSDSVIL CCCEEEECCCCEEEE | 30.89 | 29743597 | |
369 | Phosphorylation | DKLTLSGSDSVILGD CEEEECCCCEEEECC | 24.28 | 25159151 | |
371 | Phosphorylation | LTLSGSDSVILGDTT EEECCCCEEEECCCC | 16.86 | 29743597 | |
377 | Phosphorylation | DSVILGDTTTSGASD CEEEECCCCCCCCCC | 30.12 | 30624053 | |
378 | Phosphorylation | SVILGDTTTSGASDE EEEECCCCCCCCCCC | 24.57 | 30624053 | |
379 | Phosphorylation | VILGDTTTSGASDEE EEECCCCCCCCCCCC | 27.53 | 30624053 | |
380 | Phosphorylation | ILGDTTTSGASDEED EECCCCCCCCCCCCC | 30.21 | 27251275 | |
383 | Phosphorylation | DTTTSGASDEEDGQP CCCCCCCCCCCCCCC | 49.43 | 25954137 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SERC3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SERC3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
XPO5_HUMAN | XPO5 | physical | 17353931 | |
PHB2_HUMAN | PHB2 | physical | 17353931 | |
SURF4_HUMAN | SURF4 | physical | 17353931 | |
VDAC2_HUMAN | VDAC2 | physical | 17353931 | |
ERD21_HUMAN | KDELR1 | physical | 17353931 | |
HACD3_HUMAN | PTPLAD1 | physical | 17353931 | |
MOT1_HUMAN | SLC16A1 | physical | 17353931 | |
ERD22_HUMAN | KDELR2 | physical | 17353931 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...